Home › Premarket Biotech Digest: Harvoni's Label Expansion, AstraZeneca's...
 

Keywords :   


Premarket Biotech Digest: Harvoni's Label Expansion, AstraZeneca's...

2015-11-16 15:58:38| Biotech - Topix.net

Click this link to find out how much you can save.) Last week, Gilead Sciences announced that its Harvoni has been approved by the FDA in new indications. The FDA approved the blockbuster drug for expanded use in patients with genotype 4, 5 and 6 chronic HCV infections and in patients co-infected with HIV.

Tags: label expansion digest biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »